These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 21315281)
1. Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model. Gambini JP; Cabral P; Alonso O; Savio E; Figueroa SD; Zhang X; Ma L; Deutscher SL; Quinn TP Nucl Med Biol; 2011 Feb; 38(2):255-60. PubMed ID: 21315281 [TBL] [Abstract][Full Text] [Related]
2. Early detection of infarct in reperfused canine myocardium using 99mTc-glucarate. Okada DR; Johnson G; Liu Z; Hocherman SD; Khaw BA; Okada RD J Nucl Med; 2004 Apr; 45(4):655-64. PubMed ID: 15073263 [TBL] [Abstract][Full Text] [Related]
3. Effect of hypoxia on the accumulation of technetium-99m-glucarate and technetium-99m-gluconate by Chinese hamster ovary cells in vitro. Ballinger JR; Cowan DS; Boxen I; Zhang ZM; Rauth AM J Nucl Med; 1993 Feb; 34(2):242-5. PubMed ID: 8381475 [TBL] [Abstract][Full Text] [Related]
4. (99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium. Johnson G; Okada CC; Hocherman SD; Liu Z; Hart C; Khaw BA; Okada RD Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):319-28. PubMed ID: 16237571 [TBL] [Abstract][Full Text] [Related]
5. Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium. Yaoita H; Fischman AJ; Wilkinson R; Khaw BA; Juweid M; Strauss HW J Nucl Med; 1993 Aug; 34(8):1303-8. PubMed ID: 8326389 [TBL] [Abstract][Full Text] [Related]
6. A brief evaluation of tumor imaging in mice with 99mTc-glucarate including a comparison with 18F-FDG. Cheng D; Rusckowski M; Wang Y; Liu Y; Liu G; Liu X; Hnatowich D Curr Radiopharm; 2011 Jan; 4(1):5-9. PubMed ID: 22191610 [TBL] [Abstract][Full Text] [Related]
7. 99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice. Liu Z; Stevenson GD; Barrett HH; Kastis GA; Bettan M; Furenlid LR; Wilson DW; Woolfenden JM; Pak KY Nucl Med Commun; 2004 Jul; 25(7):711-20. PubMed ID: 15208499 [TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of cell death. De Saint-Hubert M; Prinsen K; Mortelmans L; Verbruggen A; Mottaghy FM Methods; 2009 Jun; 48(2):178-87. PubMed ID: 19362149 [TBL] [Abstract][Full Text] [Related]
9. MRP-1 protein expression and glutathione content of in vitro tumor cell lines derived from human glioma carcinoma U-87-MG do not interact with 99mTc-glucarate uptake. Perek N; Le Jeune N; Denoyer D; Dubois F Cancer Biother Radiopharm; 2005 Aug; 20(4):391-400. PubMed ID: 16114987 [TBL] [Abstract][Full Text] [Related]
10. Is [(99m)Tc]glucarate uptake mediated by fructose transporter GLUT-5? Isnardi V; Clotagatide A; Bruel S; Perek N Nucl Med Biol; 2012 Nov; 39(8):1226-31. PubMed ID: 23084044 [TBL] [Abstract][Full Text] [Related]
11. Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia. Okada DR; Johnson G; Liu Z; Hocherman SD; Khaw BA; Pak KY; Okada RD J Nucl Cardiol; 2003; 10(2):168-76. PubMed ID: 12673182 [TBL] [Abstract][Full Text] [Related]
12. Very early noninvasive detection of acute experimental nonreperfused myocardial infarction with 99mTc-labeled glucarate. Narula J; Petrov A; Pak KY; Lister BC; Khaw BA Circulation; 1997 Mar; 95(6):1577-84. PubMed ID: 9118528 [TBL] [Abstract][Full Text] [Related]
13. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical. Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305 [TBL] [Abstract][Full Text] [Related]
14. 99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model. Okada DR; Liu Z; Johnson G; Beju D; Khaw BA; Okada RD Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1909-17. PubMed ID: 20652807 [TBL] [Abstract][Full Text] [Related]
15. Targeting human breast tumour in xeno-grafted SCID mice with 99Tcm-glucarate. Petrov AD; Narula J; Nakazawa A; Pak KY; Khaw BA Nucl Med Commun; 1997 Mar; 18(3):241-51. PubMed ID: 9106778 [TBL] [Abstract][Full Text] [Related]
16. Localization of technetium-99m-glucarate in zones of acute cerebral injury. Yaoita H; Uehara T; Brownell AL; Rabito CA; Ahmad M; Khaw BA; Fischman AJ; Strauss HW J Nucl Med; 1991 Feb; 32(2):272-8. PubMed ID: 1704054 [TBL] [Abstract][Full Text] [Related]
17. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis. Fonge H; Chitneni SK; Lixin J; Vunckx K; Prinsen K; Nuyts J; Mortelmans L; Bormans G; Ni Y; Verbruggen A Bioconjug Chem; 2007; 18(6):1924-34. PubMed ID: 17929883 [TBL] [Abstract][Full Text] [Related]
18. 99mTc-glucarate for detection of isoproterenol-induced myocardial infarction in rats. Arteaga de Murphy C; Ferro-Flores G; Villanueva-Sanchez O; Murphy-Stack E; Pedraza-López M; Meléndez-Alafort L; Molina-Trinidad E Int J Pharm; 2002 Feb; 233(1-2):29-34. PubMed ID: 11897407 [TBL] [Abstract][Full Text] [Related]
19. Technetium 99m glucarate: what will be its clinical role? Gerson MC; McGoron AJ J Nucl Cardiol; 1997; 4(4):336-40. PubMed ID: 9278881 [TBL] [Abstract][Full Text] [Related]
20. Accumulation of technetium-99m glucarate: in vitro cell cultures and in vivo tumour models. Ballinger JR; Hsue V; Rauth AM Nucl Med Commun; 2003 May; 24(5):597-606. PubMed ID: 12717079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]